[开放获取]    老年皮肤瘙痒症诊疗与康复专家共识（2025版）

doi:10.35541/cjd.20240407

Abstract

Abstract: 【Abstract】 In recent years, research on pruritus in the elderly has progressed rapidly, deepening the understanding of this condition. In order to standardize the diagnosis, treatment and rehabilitation of pruritus in the elderly, experts from the Chinese Association Rehabilitation of Dermatology, and the Working Group on Geriatric Dermatology, Combination of Traditional and Western Medicine Dermatology organized relevant experts and formulated an expert consensus on the diagnosis, treatment, and rehabilitation of pruritus in the elderly （2025 edition） based on the latest Chinese and international research advancements, with a particular focus on evidence-based medicine. This consensus aims to provide recommendations to address clinical problems, alleviate or eliminate patients′ symptoms and improve their quality of life.

Key words: Pruritus, Aged, Diagnosis, Therapy, Rehabilitation, Expert consensus

Chinese Association of Rehabilitation Dermatology, Working Group on Geriatric Dermatology, Combination of Traditional and Western Medicine Dermatology. Expert consensus on the diagnosis, treatment, and rehabilitation of pruritus in the elderly （2025 edition）[J]. Chinese Journal of Dermatology, 2025, 58(1): 1-8.doi:10.35541/cjd.20240407

References ［69］

［1］	Valdes⁃Rodriguez R, Stull C, Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management［J］. Drugs Aging, 2015,32（3）:201⁃215. doi: 10.1007/s40266⁃015⁃0246⁃0.
［2］	Yalçin B, Tamer E, Toy GG, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients［J］. Int J Dermatol, 2006,45（6）:672⁃676. doi: 10.1111/j.1365⁃4632. 2005.02607.x.
［3］	Ju Y, Pei H, Kang N, et al. Prevalence and potential risk factors of chronic pruritus among community middle⁃aged and older population in Beijing, China［J］. J Eur Acad Dermatol Venereol, 2022,36（7）:1074⁃1079. doi: 10.1111/jdv.18041.
［4］	陈师, 高静, 柏丁兮, 等. 中国老年性皮肤瘙痒症患病率的Meta分析［J］. 中国循证医学杂志, 2020,20（5）:562⁃567. doi: 10.7507/1672⁃2531.201910023.
［5］	Calimport S, Bentley BL. Aging classified as a cause of disease in ICD⁃11［J］. Rejuvenation Res, 2019,22（4）:281. doi: 10.1089/rej.2019.2242.
［6］	Clerc CJ, Misery L. A literature review of senile pruritus: from diagnosis to treatment［J］. Acta Derm Venereol, 2017,97（4）:433⁃440. doi: 10.2340/00015555⁃2574.
［7］	谢志强. 老年瘙痒症:从症状到疾病［J］. 皮肤科学通报, 2019,36（4）:480⁃490.
［8］	Abel MK, Jelousi S, Berger T, et al. Immunological eruptions of ageing: reframing chronic pruritic rashes in older adults［J］. Br J Dermatol, 2021,185（3）:638⁃639. doi: 10.1111/bjd.20414.
［9］	中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. 老年皮肤瘙痒症诊断与治疗专家共识［J］. 中国皮肤性病学杂志, 2018,32（11）:1233⁃1237. doi: 10.13735/j.cjdv.1001⁃7089. 201808168.
［10］	Berger TG, Steinhoff M. Pruritus in elderly patients⁃⁃eruptions of senescence［J］. Semin Cutan Med Surg, 2011,30（2）:113⁃117. doi: 10.1016/j.sder.2011.04.002.
［11］	Steinhoff M, Al⁃Khawaga S, Buddenkotte J. Itch in elderly patients: origin, diagnostics, management［J］. J Allergy Clin Immunol, 2023,152（1）:42⁃49. doi: 10.1016/j.jaci.2023.05.009.
［12］	Roh YS, Khanna R, Patel SP, et al. Circulating blood eosinophils as a biomarker for variable clinical presentation and therapeutic response in patients with chronic pruritus of unknown origin［J］. J Allergy Clin Immunol Pract, 2021,9（6）:2513⁃2516.e2. doi: 10.1016/j.jaip.2021.01.034.
［13］	Roh YS, Choi J, Sutaria N, et al. Itch: epidemiology, clinical presentation, and diagnostic workup［J］. J Am Acad Dermatol, 2022,86（1）:1⁃14. doi: 10.1016/j.jaad.2021.07.076.
［14］	中国医师协会皮肤科医师分会. 慢性瘙痒管理指南（2024版）［J］. 中华皮肤科杂志, 2024,57（5）:387⁃399. doi: 10.35541/cjd.20230746.
［15］	Reich A, Chatzigeorkidis E, Zeidler C, et al. Tailoring the cut⁃off values of the visual analogue scale and numeric rating scale in itch assessment［J］. Acta Derm Venereol, 2017,97（6）:759⁃760. doi: 10.2340/00015555⁃2642.
［16］	谢志强, 傅君舟, 陈敢, 等. 改良川岛瘙痒严重度评价方法与视觉模拟评分法的相关性［J］. 中国医学科学院学报, 2018,40（4）:539⁃542. doi: 10.3881/j.issn.1000⁃503X.10320.
［17］	Bastien CH, Vallières A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research［J］. Sleep Med, 2001,2（4）:297⁃307. doi: 10.1016/s1389⁃9457（00）00065⁃4.
［18］	Zigmond AS, Snaith RP. The hospital anxiety and depression scale［J］. Acta Psychiatr Scand, 1983,67（6）:361⁃370. doi: 10. 1111/j.1600⁃0447.1983.tb09716.x.
［19］	Finlay AY, Khan GK. Dermatology life quality index （DLQI）⁃⁃a simple practical measure for routine clinical use［J］. Clin Exp Dermatol, 1994,19（3）:210⁃216. doi: 10.1111/j.1365⁃2230.1994.tb01167.x.
［20］	Choi EH. Gender, age, and ethnicity as factors that can influence skin pH［J］. Curr Probl Dermatol, 2018,54:48⁃53. doi: 10.1159/000489517.
［21］	Wang Z, Man MQ, Li T, et al. Aging⁃associated alterations in epidermal function and their clinical significance［J］. Aging （Albany NY）, 2020,12（6）:5551⁃5565. doi: 10.18632/aging. 102946.
［22］	Wang B, Han J, Elisseeff JH, et al. The senescence⁃associated secretory phenotype and its physiological and pathological implications［J］. Nat Rev Mol Cell Biol, 2024,25（12）:958⁃978. doi: 10.1038/s41580⁃024⁃00727⁃x.
［23］	Du LX, Zhu JY, Mi WL. Cytokines and chemokines modulation of itch［J］. Neuroscience, 2022,495:74⁃85. doi: 10.1016/j.neuroscience.2022.05.035.
［24］	Mansfield AS, Nevala WK, Dronca RS, et al. Normal ageing is associated with an increase in Th2 cells, MCP⁃1 （CCL1） and RANTES （CCL5）, with differences in sCD40L and PDGF⁃AA between sexes［J］. Clin Exp Immunol, 2012,170（2）:186⁃193. doi: 10.1111/j.1365⁃2249.2012.04644.x.
［25］	Terekhova M, Swain A, Bohacova P, et al. Single⁃cell atlas of healthy human blood unveils age⁃related loss of NKG2C（+）GZMB（⁃）CD8（+） memory T cells and accumulation of type 2 memory T cells［J］. Immunity, 2024,57（1）:188⁃192. doi: 10. 1016/j.immuni.2023.12.014.
［26］	Oetjen LK, Mack MR, Feng J, et al. Sensory neurons co⁃opt classical immune signaling pathways to mediate chronic itch［J］. Cell, 2017,171（1）:217⁃228.e13. doi: 10.1016/j.cell.2017.08.006.
［27］	Sutaria N, Adawi W, Goldberg R, et al. Itch: pathogenesis and treatment［J］. J Am Acad Dermatol, 2022,86（1）:17⁃34. doi: 10.1016/j.jaad.2021.07.078.
［28］	Feng J, Luo J, Yang P, et al. Piezo2 channel⁃Merkel cell signaling modulates the conversion of touch to itch［J］. Science, 2018,360（6388）:530⁃533. doi: 10.1126/science.aar5703.
［29］	Hadad R, Mandelli ML, Rankin KP, et al. Itching frequency and neuroanatomic correlates in frontotemporal lobar degeneration［J］. JAMA Neurol, 2024,81（9）:977⁃984. doi: 10.1001/jamaneurol. 2024.2213.
［30］	Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient［J］. Mayo Clin Proc, 2003,78（12）:1564⁃1577. doi: 10. 4065/78.12.1564.
［31］	Nowak DA, Yeung J. Diagnosis and treatment of pruritus［J］. Can Fam Physician, 2017,63（12）:918⁃924.
［32］	程淋燕, 王怡, 卫颖漪, 等. 三亚油酸甘油酯对皮肤屏障的保护作用研究［J］. 皮肤科学通报, 2024,41（03）:299⁃304.
［33］	Wang Y, Lu H, Cheng L, et al. Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: a triacylglycerol from the medicinal plant Cannabis fructus［J］. Phytomedicine, 2024,132:155856. doi: 10.1016/j.phymed.2024.155856.
［34］	Katayama I, Aihara M, Ohya Y, et al. Japanese guidelines for atopic dermatitis 2017［J］. Allergol Int, 2017,66（2）:230⁃247. doi: 10.1016/j.alit.2016.12.003.
［35］	Hayama K, Takano Y, Tamura J, et al. Effectiveness of a heparinoid⁃containing moisturiser to treat senile xerosis［J］. Australas J Dermatol, 2015,56（1）:36⁃39. doi: 10.1111/ajd.12179.
［36］	Valdes⁃Rodriguez R, Stull C, Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management［J］. Drugs Aging, 2015,32（3）:201⁃215. doi: 10.1007/s40266⁃015⁃0246⁃0.
［37］	Nowak DA, Yeung J. Diagnosis and treatment of pruritus［J］. Can Fam Physician, 2017,63（12）:918⁃924.
［38］	Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the medical board of the national psoriasis foundation［J］. J Am Acad Dermatol, 2011,65（3）:537⁃545. doi: 10.1016/j.jaad.2010.05.014.
［39］	Al⁃Ghnaniem R, Short K, Pullen A, et al. 1% hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial［J］. Int J Colorectal Dis, 2007,22（12）:1463. doi: 10.1007/s00384⁃007⁃0325⁃8.
［40］	Sher LG, Chang J, Patel IB, et al. Relieving the pruritus of atopic dermatitis: a meta⁃analysis［J］. Acta Derm Venereol, 2012,92（5）:455⁃461. doi: 10.2340/00015555⁃1360.
［41］	Duque MI, Yosipovitch G, Fleischer AB Jr, et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis⁃related pruritus: a randomized, double⁃blind, vehicle⁃controlled study［J］. J Am Acad Dermatol, 2005,52（3 Pt 1）:519⁃521. doi: 10.1016/j.jaad.2004.08.050.
［42］	Yosipovitch G, Gold LF, Lebwohl MG, et al. Early relief of pruritus in atopic dermatitis with crisaborole ointment, a non⁃steroidal, phosphodiesterase 4 inhibitor［J］. Acta Derm Venereol, 2018,98（5）:484⁃489. doi: 10.2340/00015555⁃2893.
［43］	Ciechanowicz P, Rakowska A, Sikora M, et al. JAK⁃inhibitors in dermatology: current evidence and future applications［J］. J Dermatolog Treat, 2019,30（7）:648⁃658. doi: 10.1080/09546634. 2018.1546043.
［44］	Chen X, Han X, Cheng B, et al. Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: a multicenter, double⁃blind, double⁃dummy, phase Ⅲ, non⁃inferiority, randomized clinical trial［J］. Chin Med J （Engl）, 2024,137（12）:1480⁃1482. doi: 10.1097/CM9.0000000000003071.
［45］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 抗组胺药在皮肤科应用专家共识［J］. 中华皮肤科杂志, 2017,50（6）:393⁃396. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.06.001.
［46］	Yasuda KI, Ishiuji Y, Endo T, et al. Cyclosporine improves sleep quality in patients with atopic dermatitis［J］. Dermatol Ther （Heidelb）, 2020,10（6）:1359⁃1369. doi: 10.1007/s13555⁃020⁃00451⁃2.
［47］	Wollenberg A, Barbarot S, Bieber T, et al. Consensus⁃based European guidelines for treatment of atopic eczema （atopic dermatitis） in adults and children: part Ⅱ［J］. J Eur Acad Dermatol Venereol, 2018,32（6）:850⁃878. doi: 10.1111/jdv. 14888.
［48］	Kursewicz C, Valdes⁃Rodriguez R, Yosipovitch G. Methotrexate in the treatment of chronic itch in the geriatric population［J］. Acta Derm Venereol, 2020,100（1）:adv00037. doi: 10.2340/00015555⁃3360.
［49］	Matsuda KM, Sharma D, Schonfeld AR, et al. Gabapentin and pregabalin for the treatment of chronic pruritus［J］. J Am Acad Dermatol, 2016,75（3）:619⁃625.e6. doi: 10.1016/j.jaad.2016. 02.1237.
［50］	Lee J, Shin JU, Noh S, et al. Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus［J］. Ann Dermatol, 2016,28（2）:159⁃163. doi: 10.5021/ad.2016.28.2.159.
［51］	Raap U, Ständer S, Metz M. Pathophysiology of itch and new treatments［J］. Curr Opin Allergy Clin Immunol, 2011,11（5）:420⁃427. doi: 10.1097/ACI.0b013e32834a41c2.
［52］	Kumagai H, Ebata T, Takamori K, et al. Effect of a novel kappa⁃receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase Ⅲ, randomized, double⁃blind, placebo⁃controlled study［J］. Nephrol Dial Transplant, 2010,25（4）:1251⁃1257. doi: 10.1093/ndt/gfp588.
［53］	Weiner DE, Schaufler T, McCafferty K, et al. Difelikefalin improves itch⁃related sleep disruption in patients undergoing haemodialysis［J］. Nephrol Dial Transplant, 2024,39（7）:1125⁃1137. doi: 10.1093/ndt/gfad245.
［54］	Alsebayel MM, Alzaid T, Alobaida SA. Dupilumab in acquired perforating dermatosis: a potential new treatment［J］. JAAD Case Rep, 2022,28:34⁃36. doi: 10.1016/j.jdcr.2022.08.013.
［55］	Jeon J, Wang F, Badic A, et al. Treatment of patients with chronic pruritus of unknown origin with dupilumab［J］. J Dermatolog Treat, 2022,33（3）:1754⁃1757. doi: 10.1080/09546634.2021.1880542.
［56］	Bal A, Sorensen A, Ondreyco SM. Nonbullous erythrodermic pemphigoid with florid lymphadenopathy, response to dupilumab［J］. JAAD Case Rep, 2021,17:58⁃60. doi: 10.1016/j.jdcr.2021. 09.014.
［57］	Guttman⁃Yassky E, Bissonnette R, Ungar B, et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis［J］. J Allergy Clin Immunol, 2019,143（1）:155⁃172. doi: 10.1016/j.jaci.2018.08.022.
［58］	Wu K, Jabbar⁃Lopez ZK. Omalizumab, an anti⁃IgE mAb, receives approval for the treatment of chronic idiopathic/spontaneous urticaria［J］. J Invest Dermatol, 2015,135（1）:13⁃15. doi: 10.1038/jid.2014.362.
［59］	中华医学会皮肤性病学分会荨麻疹研究中心. 抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识［J］. 中华皮肤科杂志, 2021,54（12）:1057⁃1062. doi: 10.35541/cjd.20210568.
［60］	Guttman⁃Yassky E, Thaçi D, Pangan AL, et al. Upadacitinib in adults with moderate to severe atopic dermatitis: 16⁃week results from a randomized, placebo⁃controlled trial［J］. J Allergy Clin Immunol, 2020,145（3）:877⁃884. doi: 10.1016/j.jaci.2019.11. 025.
［61］	Eichenfield LF, Flohr C, Sidbury R, et al. Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate⁃to⁃severe atopic dermatitis: the JADE TEEN randomized clinical trial［J］. JAMA Dermatol, 2021,157（10）:1165⁃1173. doi: 10.1001/jamadermatol.2021.2830.
［62］	Wang F, Morris C, Bodet ND, et al. Treatment of refractory chronic pruritus of unknown origin with tofacitinib in patients with rheumatoid arthritis［J］. JAMA Dermatol, 2019,155（12）:1426⁃1428. doi: 10.1001/jamadermatol.2019.2804.
［63］	Buttgereit T, Grekowitz EM, Metz M. Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab［J］. JAAD Case Rep, 2021,15:36⁃38. doi: 10.1016/j.jdcr.2021.06.028.
［64］	Kwatra SG, Bordeaux ZA, Parthasarathy V, et al. Efficacy and safety of abrocitinib in prurigo nodularis and chronic pruritus of unknown origin: a nonrandomized controlled Trial［J］. JAMA Dermatol, 2024,160（7）:717⁃724. doi: 10.1001/jamadermatol. 2024.1464.
［65］	中华中医药学会皮肤科分会. 皮肤瘙痒症中医治疗专家共识［J］. 中国中西医结合皮肤性病学杂志, 2017,16（2）:189⁃190. doi: 10.3969/j.issn.1672⁃0709.2017.02.036.
［66］	李斌, 陈达灿.中西医结合皮肤性病学［M］. 北京: 中国中医药出版社, 2017.
［67］	Chung BY, Um JY, Kim JC, et al. Pathophysiology and treatment of pruritus in elderly［J］. Int J Mol Sci, 2020,22（1）:174. doi: 10.3390/ijms22010174.
［68］	Schut C, Mollanazar NK, Kupfer J, et al. Psychological interventions in the treatment of chronic itch［J］. Acta Derm Venereol, 2016,96（2）:157⁃161. doi: 10.2340/00015555⁃2177.
［69］	凯特林·弗朗卡. 应激与皮肤疾病—从基础到临床［M］. 张海萍, 译. 北京: 清华大学出版社, 2021.

[1]	Qin Bei, Li Qinfeng. Blueberry muffin baby: advances in the etiology [J]. Chinese Journal of Dermatology, 2025, 58(3): 20220411-e20220411.
[2]	Xu Zhuohong, Hu Yu, Gu Heng. Role of mesenchymal stem cell?derived exosomes in skin diseases [J]. Chinese Journal of Dermatology, 2025, 58(3): 20220881-e20220881.
[3]	Combination of Traditional and Western Medicine Dermatology, Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on reflectance confocal microscopic features of common non-melanocytic skin tumors （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(1): 20-33.
[4]	Chinese Association of Rehabilitation Dermatology, Chinese Association of Photodynamic Therapy and Rehabilitation, Photodynamic Therapy Cooperation Center, Chinese Society of Dermatology . Expert consensus on clinical application of aminolevulinic acid photodynamic therapy in non-melanoma skin cancers （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(1): 9-19.
[5]	Liao Caihe, Wang Peiru, Wu Mingshun, Sun Xiaofei, Zhang Guolong, Wang Xiuli. Efficacy and safety of combination therapy with aminolevulinic acid photodynamic therapy in the treatment of facial basal cell carcinoma in the elderly: a retrospective analysis [J]. Chinese Journal of Dermatology, 2025, 58(1): 34-39.
[6]	Wu Caoying, Yang Yongting, Wang Chun, Shen Yaoyuan, Jia Huihui, Li Tingting, Zhao Juan, Kang Xiaojing. Clinicopathological features and prognostic analysis of melanoma in the elderly [J]. Chinese Journal of Dermatology, 2025, 58(1): 40-46.
[7]	Jin Lan, Qiu Yun, Wang Weijia, Kang Xiaojing, Ding Yuan. Clinical efficacy and safety of biological agents in the treatment of moderate-to-severe psoriasis in 124 elderly patients: a retrospective analysis [J]. Chinese Journal of Dermatology, 2025, 58(1): 47-52.
[8]	Wang Bo, Zheng Jie. Considerations in the treatment of elderly patients with psoriasis and atopic dermatitis using biologics and small-molecule drugs [J]. Chinese Journal of Dermatology, 2025, 58(1): 72-75.
[9]	Yang Zijing, Chen Lihong, Ruan Yeping, Wen Wanting, Zhang Jiayi, Wang Hailun, Pan Meng, Zhao Xiaoqing. Efficacy and safety of dupilumab in the treatment of atopic dermatitis in the elderly [J]. Chinese Journal of Dermatology, 2025, 58(1): 65-69.
[10]	Ai Fangting, Sun Zijun, Miao Guoying, Yao Chunxia. Role of calcium-sensing receptors in the pathophysiology of skin of the elderly [J]. Chinese Journal of Dermatology, 2025, 58(1): 76-79.
[11]	Lu Qing, Liu Yanqiu, Liu Danping, Zou Yongyi, Yang Bicheng. Variation analysis and prenatal diagnosis in a pedigree with oculocutaneous albinism [J]. Chinese Journal of Dermatology, 2024, 57(9): 842-843.
[12]	Wang Ruixia, Qu Yanlei, Ai Wenjin, Yan Lin, Qu Caijie, Shi Tongxin. A case of nonbullous neutrophilic lupus erythematosus [J]. Chinese Journal of Dermatology, 2024, 57(9): 832-834.
[13]	Zou Xianbiao, Chen Jinchun, Zeng Yue, Hao Yi. Application of ultrasonography in dermatology: progress and prospects [J]. Chinese Journal of Dermatology, 2024, 57(9): 785-790.
[14]	Xiang Xi, Zhang Lingyan, Zhong Lin, Gao Yi, Qiu Li. Multimodal ultrasound manifestations of port-wine stains and their application in efficacy assessment of photodynamic therapy [J]. Chinese Journal of Dermatology, 2024, 57(9): 801-806.
[15]	Zeng Yue, Shao Huihong, Lin Shiwen, Wen Rou, Zou Xianbiao. Application of a wearable teleconsultation device in diagnosis of common skin diseases [J]. Chinese Journal of Dermatology, 2024, 57(9): 797-800.

Expert consensus on the diagnosis, treatment, and rehabilitation of pruritus in the elderly （2025 edition）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［69］

Related Articles 15

Metrics

Comments

Recommended 10